参考文献/References:
[1] 郭智勇,陈垦,李敏,等.瘢痕子宫再次妊娠阴道试产及母婴结局影响因素分析[J].护士进修杂志,2020,35(7):654-657.
GUO Z Y,CHEN K,LI M,et al.Analysis of factors influencing vaginal trial delivery,maternal and infant outcome in the subsequent pregnancy of scarred uterus[J].J Nurs Train,2020,35(7):654-657.
[2] 张若,张鸢,贾利平.瘢痕子宫妊娠剖宫产术后切口感染特点及危险因素研究[J].中国妇产科临床杂志,2021,22(5):534-535.
ZHANG R,ZHANG Y,JIA L P.Study on the characteristics and risk factors of incision infection after caesarean section in cicatricial uterine pregnancy[J].Chin J Clin Obstetr Gyn Ecol,2021,22(5):534-535.
[3] 唐锦清,桂华,施艳,等.经阴道分娩方式对疤痕子宫再次妊娠产妇免疫及应激效果的影响[J].贵州医科大学学报,2022,47(7):826-830.
TANG J Q,GUI H,SHI Y,et al.Effect of vaginal delivery on immune and stress responses of re-pregnant women with scarred uterus[J].J Guizhou Med Univ,2022,47(7):826-830.
[4] ENDE H B,LOZADA M J,CHESTNUT D H,et al.Risk factors for atonic postpartum hemorrhage:a systematic review and meta-analysis[J].Obstet Gynecol,2021,137(2):305-323.
[5] KUMARASWAMI S,BUTWICK A.Latest advances in postpartum hemorrhage management[J].Best Pract Res Clin Anaesthesiol,2022,36(1):123-134.
[6] 刘慧丽,王雪莹,姚莉芸,等.孕妇血清THBS-1,AT-Ⅲ和25(OH)D 表达水平对产后出血的预测价值分析[J].现代检验医学杂志,2021,36(4):106-110.
LIU H L,WANG X Y,YAO L Y,et al.Predictive value analysis of maternal serum THBS-1,AT-Ⅲ and 25(OH)D expression levels for postpartum hemorrhage[J].J Mod Lab Med,2021,36(4):106-110.
[7] 王红,杨雯,周燕,等.血清PLT、Hb及D-D水平预测产后出血的临床价值[J].中国妇产科临床杂志,2021,22(1):42-44.
WANG H,YANG W,ZHOU Y,et al.Clinical value of serum PLT,Hb and D-D levels in predicting postpartum hemorrhage[J].Chin J Clin Obstetrics Gyn Ecol,2021,22(1):42-44.
[8] 黄蕾,贾娟,邢丽丽.宫腔粘连患者血清MMP-9、TIMP-1水平与三维能量超声参数关系[J].中国计划生育学杂志,2022,30(1):181-184.
HUANG L,JIA J,XING L L.Correlation between serum matrix MMP- 9 and TIMP-1 levels of patients with intrauterine adhesions and their values of blood flow parameters examined by three-dimensional energy ultrasonic[J].Chin J Fam Plan,2022,30(1):181-184.
[9] 金力,陈蔚琳,周应芳.剖宫产术后子宫瘢痕妊娠诊治专家共识(2016)[J].中华妇产科杂志,2016,51(8):568-572.
JIN L,CHEN W L,ZHOU Y F.Expert consensus on the diagnosis and treatment of uterine scar pregnancy after cesarean section (2016)[J].Chin J Obstet Gynecol,2016,51(8):568-572.
[10] VOON H Y,SUHARJONO H N,SHAFIE A A,et al.Carbetocin versus oxytocin for the prevention of postpartum hemorrhage:a meta-analysis of randomized controlled trials in cesarean deliveries [J].Taiwan J Obstet Gynecol,2018,57(3):332-339.
[11] 蒋一逍,李力,刘宿,等.纤维蛋白原在产后出血中的临床应用研究进展[J].解放军医学杂志,2021,46(5):498-503.
JAING Y X,LI L,LIU S,et al.Research progress of fibrinogen in the clinical assessment and treatment of postpartum hemorrhage[J].Med J Chin PLA,2021,46(5):498-503.
[12] 马海英.卡前列素氨丁三醇在预防瘢痕子宫再次剖宫产产后出血的有效性及安全性观察[J].重庆医学,2021,50(S01):293-295.
MA H Y.Observation on the effectiveness and safety of carboprost tromethamine in preventing postpartum bleeding after caesarean section of scar uterus[J].Chongqing Med,2021,50(S01):293-295.
[13] WANG P,ZENG Z,LIN C,et al.Thrombospondin-1 as a potential therapeutic target:multiple roles in cancers[J].Curr Pharm Des,2020,26(18):2116-2136.
[14] ABURIMA A,BERGER M,SPURGEON B E J,et al.Thrombospondin-1 promotes hemostasis through modulation of CAMP signaling in blood platelets[J].Blood,2021,137(5):678-689.
[15] 张亚崴,张利萍,于治芳.复发性流产患者PAI-1、TSP-1、D-D水平变化及其临床意义[J].分子诊断与治疗杂志,2021,13(11):1858-1861.
ZHANG Y W,ZHANG L P,YU Z F,et al.Changes and clinical significance of PAI-1,TSP-1 and D-D levels in patients with recurrent spontaneous abortion[J].J Mol Diag Ther,2021,13(11):1858-1861.
[16] SHAO H,GAO S,DAI D,et al.The association of antenatal D-dimer and fibrinogen with postpartum hemorrhage and intrauterine growth restriction in preeclampsia[J].BMC Pregnancy Childbirth,2021,21(1):605-614.
[17] 王留香,王川红.血浆FDP、D-D及血清NO、NOS与产后出血的关系研究[J].实验与检验医学,2020,38(3):462-465.
WANG L X,WANG C H.Study on the relationship between plasma FDP,D-D,serum NO,NOS and postpartum hemorrhage[J].Exp Lab Med,2020,38(3):462-465.
[18] 许敏华,薛婷.D-二聚体对瘢痕子宫患者产后出血的预测价值[J].临床与病理杂志,2022,42(12):2965-2970.
XU M H,XUE T.Predictive value of D-dimer for postpartum hemorrhage in patients with scarred uterus[J].J Clin Pathol Res,2022,42(12):2965-2970.
[19] 孔振兴,马恺,韩娜,等.血清MMP-9、TIMP-1、TNF-α及IL-10在未足月胎膜早破而早产产妇中的表达及临床意义[J].现代生物医学进展,2020,20(21):4168-4171.
KONG Z X,MA K,HAN N,et al.The expression and clinical significance of serum MMP-9,TIMP-1,TNF-α and IL-10 in premature parturients with preterm premature rupture of membranes [J].Prog Mod Biomed,2020,20(21):4168-4171.
[20] 唐连敏,付翠芳,宁超,等.产后逐瘀胶囊治疗产后出血的机制研究[J].西北药学杂志,2021,36(1):57-61.
TANG L M,FU C F,NING C,et al.Study on the mechanism of Chanhou Zhuyu Capsules in the treatment of postpartum hemo-rrhage[J].Northwest Pharm J,2021,36(1):57-61.